albuterol has been researched along with Liver Neoplasms in 1 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Liver Neoplasms: Tumors or cancer of the LIVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kersten, S | 1 |
| Lichtenstein, L | 1 |
| Steenbergen, E | 1 |
| Mudde, K | 1 |
| Hendriks, HF | 1 |
| Hesselink, MK | 1 |
| Schrauwen, P | 1 |
| Müller, M | 1 |
1 trial available for albuterol and Liver Neoplasms
| Article | Year |
|---|---|
Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Angiopoietin-Like Protein 4; Angiopoietins; Animals; Cal | 2009 |